we investigated clinical efficacy of green tea extracts polyphenon e poly e and epigallocatechin3gallate egcg delivered in a form of ointment or capsule in patients with human papilloma virus hpv infected cervical lesionsfiftyone patients with cervical lesions chronic cervicitis mild dysplasia moderate dysplasia and severe dysplasia were divided into four groups as compared with 39 untreated patients as a controlpoly e ointment was applied locally to 27 patients twice a weekfor oral delivery a 200 mg of poly e or egcg capsule was taken orally every day for eight to 12 weeksin the study 20 out of 27 patients 74 under poly e ointment therapy showed a responsesix out of eight patients under poly e ointment plus poly e capsule therapy 75 showed a response and three out of six patients 50 under poly e capsule therapy showed a responsesix out of 10 patients 60 under egcg capsule therapy showed a responseoverall a 69 response rate 3551 was noted for treatment with green tea extracts as compared with a 10 response rate 439 in untreated controls p005thus the data collected here demonstrated that green tea extracts in a form of ointment and capsule are effective for treating cervical lesions suggesting that green tea extracts can be a potential therapy regimen for patients with hpv infected cervical lesions